FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034171544> ?p ?o ?g. }

• W2034171544 endingPage "373" @default.
• W2034171544 startingPage "366" @default.
• W2034171544 abstract "Recent studies indicate that type 2 diabetes is associated with an increased secretion of both hepatic and intestinal lipoproteins, leading to the accumulation of atherogenic triglyceride (TG)-rich lipoproteins. Sitagliptin is a selective inhibitor of dipeptidyl peptidase-4 that has been shown to reduce fasting and postprandial glucose levels in patients with type 2 diabetes presumably through incretin hormone-mediated improvements in islet function. The objective of the present study is to examine the effects of treatment with sitagliptin on postprandial lipid and incretin hormone levels as well as glucose homeostasis in patients with type 2 diabetes.Thirty-six subjects with type 2 diabetes (30 men/6 postmenopausal women with a mean age of 58.1 ± 6.4 years and a body mass index of 30.7 ± 4.9 kg/m(2) ) were recruited in this double-blind cross-over study using sitagliptin 100 mg/day or placebo for a 6-week period each, with a 4-week washout period between the two phases. At the end of each phase of treatment, patients underwent an oral lipid tolerance test providing 35 g of fat per m(2) of body surface area and blood samples were taken over an 8-h period.Sitagliptin therapy significantly decreased the postprandial area under the curves (AUCs) for plasma apolipoprotein (apo)B (-5.1%, p = 0.002), apoB-48 (-7.8%, p = 0.03), TG (-9.4%, p = 0.006), very low-density lipoprotein (VLDL)-cholesterol (-9.3%, p = 0.001), free fatty acids (FFAs) (-7.6%, p = 0.005) and glucose (-9.7%, p < 0.0001). Furthermore, the postprandial AUCs for plasma intact glucagon-like peptide-1 (+67.8%, p < 0.0001) and glucose-dependent insulinotropic polypeptide (+67.3%, p < 0.0001) were significantly increased following treatment with sitagliptin, whereas the AUC for plasma glucagon was reduced by -9.7% (p = 0.001) with no significant changes in the AUCs for plasma insulin and C-peptide. Sitagliptin therapy also improved homeostasis model assessment (HOMA) index for insulin resistance (-14.6%, p = 0.01) and β-cell function (+32.3%, p = 0.007).Treatment with sitagliptin for 6 weeks reduced postprandial plasma levels of TG-rich lipoproteins of both intestinal and hepatic origin, most likely by increasing incretin hormone levels, reducing circulating plasma FFA concentrations and improving insulin sensitivity and β-cell function." @default.
• W2034171544 created "2016-06-24" @default.
• W2034171544 creator A5016257333 @default.
• W2034171544 creator A5026754214 @default.
• W2034171544 creator A5054335526 @default.
• W2034171544 creator A5087425230 @default.
• W2034171544 creator A5088704695 @default.
• W2034171544 date "2011-02-23" @default.
• W2034171544 modified "2023-10-12" @default.
• W2034171544 title "Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes" @default.
• W2034171544 cites W1966372003 @default.
• W2034171544 cites W1967477040 @default.
• W2034171544 cites W1970498822 @default.
• W2034171544 cites W1975936284 @default.
• W2034171544 cites W1976077381 @default.
• W2034171544 cites W1977226383 @default.
• W2034171544 cites W1980130009 @default.
• W2034171544 cites W1989743926 @default.
• W2034171544 cites W1990805315 @default.
• W2034171544 cites W1994743271 @default.
• W2034171544 cites W1997129422 @default.
• W2034171544 cites W1999752077 @default.
• W2034171544 cites W2000083483 @default.
• W2034171544 cites W2007032642 @default.
• W2034171544 cites W2012799511 @default.
• W2034171544 cites W2018192866 @default.
• W2034171544 cites W2022458426 @default.
• W2034171544 cites W2029451802 @default.
• W2034171544 cites W2032622596 @default.
• W2034171544 cites W2035848639 @default.
• W2034171544 cites W2036167841 @default.
• W2034171544 cites W2041101952 @default.
• W2034171544 cites W2054185381 @default.
• W2034171544 cites W2056288576 @default.
• W2034171544 cites W2065323334 @default.
• W2034171544 cites W2082319637 @default.
• W2034171544 cites W2082707171 @default.
• W2034171544 cites W2083473802 @default.
• W2034171544 cites W2085862152 @default.
• W2034171544 cites W2086985270 @default.
• W2034171544 cites W2087707716 @default.
• W2034171544 cites W2097785866 @default.
• W2034171544 cites W2101293928 @default.
• W2034171544 cites W2103962195 @default.
• W2034171544 cites W2108589716 @default.
• W2034171544 cites W2110774736 @default.
• W2034171544 cites W2128566496 @default.
• W2034171544 cites W2135503869 @default.
• W2034171544 cites W2139470767 @default.
• W2034171544 cites W2143014102 @default.
• W2034171544 cites W2143440758 @default.
• W2034171544 cites W2147891699 @default.
• W2034171544 cites W2148986433 @default.
• W2034171544 cites W2149433053 @default.
• W2034171544 cites W2152978153 @default.
• W2034171544 cites W2159581689 @default.
• W2034171544 cites W2160234571 @default.
• W2034171544 cites W2164884154 @default.
• W2034171544 cites W2169582126 @default.
• W2034171544 cites W2171512247 @default.
• W2034171544 cites W2922316283 @default.
• W2034171544 cites W4230178491 @default.
• W2034171544 cites W4234825176 @default.
• W2034171544 cites W4239773873 @default.
• W2034171544 cites W4242367173 @default.
• W2034171544 cites W4245253826 @default.
• W2034171544 cites W4247754326 @default.
• W2034171544 cites W4249050645 @default.
• W2034171544 cites W49041740 @default.
• W2034171544 doi "https://doi.org/10.1111/j.1463-1326.2011.01362.x" @default.
• W2034171544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21226820" @default.
• W2034171544 hasPublicationYear "2011" @default.
• W2034171544 type Work @default.
• W2034171544 sameAs 2034171544 @default.
• W2034171544 citedByCount "147" @default.
• W2034171544 countsByYear W20341715442012 @default.
• W2034171544 countsByYear W20341715442013 @default.
• W2034171544 countsByYear W20341715442014 @default.
• W2034171544 countsByYear W20341715442015 @default.
• W2034171544 countsByYear W20341715442016 @default.
• W2034171544 countsByYear W20341715442017 @default.
• W2034171544 countsByYear W20341715442018 @default.
• W2034171544 countsByYear W20341715442019 @default.
• W2034171544 countsByYear W20341715442020 @default.
• W2034171544 countsByYear W20341715442021 @default.
• W2034171544 countsByYear W20341715442022 @default.
• W2034171544 countsByYear W20341715442023 @default.
• W2034171544 crossrefType "journal-article" @default.
• W2034171544 hasAuthorship W2034171544A5016257333 @default.
• W2034171544 hasAuthorship W2034171544A5026754214 @default.
• W2034171544 hasAuthorship W2034171544A5054335526 @default.
• W2034171544 hasAuthorship W2034171544A5087425230 @default.
• W2034171544 hasAuthorship W2034171544A5088704695 @default.
• W2034171544 hasConcept C126322002 @default.
• W2034171544 hasConcept C134018914 @default.
• W2034171544 hasConcept C156490143 @default.
• W2034171544 hasConcept C2777180221 @default.
• W2034171544 hasConcept C2777391703 @default.

• next